About Anmarate
Anmarate is a company based in George (South Africa) founded in 1996 was acquired by Cipla Medpro in March 2017. Anmarate operates in a competitive market with competitors including AmerisourceBergen, Activo Health, Brunel, Rand Pharmaceutical Distributors and Siyeza Fine Chem, among others.
- Headquarter George, South Africa
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Cipla Medpro
(Mar 31, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Anmarate
Detailed funding history for Anmarate
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Anmarate
Anmarate has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Cipla Medpro.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Generic pharmaceuticals are manufactured and marketed for South African customers.
|
Locked | Locked | Locked |
Investor details for Anmarate
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Anmarate
Investment portfolio details for Anmarate
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Anmarate
Detailed financials for Anmarate
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Anmarate Comparisons
Peer comparison for Anmarate
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Anmarate
Anmarate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Activo Health, Brunel, Rand Pharmaceutical Distributors and Siyeza Fine Chem, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Pharmaceutical products are distributed by Activo Health in South Africa.
|
|
| Locked | Locked | Locked |
Diversified drugs are distributed by Brunel in South Africa.
|
|
| Locked | Locked | Locked |
Pharmaceutical products are distributed in South Africa by the company.
|
|
| Locked | Locked | Locked |
Distributor of pharmaceutical products
|
Detailed competitors of Anmarate
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Anmarate
Complete news archive for Anmarate
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anmarate
Anmarate was founded in 1996.
Anmarate is headquartered in George, South Africa. It is registered at George, Western Cape, South Africa.
Paul Miller is the current CEO of Anmarate.
Anmarate was founded in 1996 and is headquartered in George, South Africa. Operations center on research and development as well as manufacturing of pharmaceutical drugs targeting various therapeutic areas. The company functions within the biotechnology and pharmaceuticals sector, with activities supported by a domain at anmarate.co.za. Leadership is provided by CEO Paul Miller, overseeing core functions in drug production.
Anmarate's top competitors include AmerisourceBergen, Activo Health and Brunel.
Anmarate has 1 investor. Key investors include Cipla Medpro.